Literature DB >> 8841654

Estimating confidence intervals for cost-effectiveness ratios: an example from a randomized trial.

M A Chaudhary1, S C Stearns.   

Abstract

Cost-effectiveness ratios usually appear as point estimates without confidence intervals, since the numerator and denominator are both stochastic and one cannot estimate the variance of the estimator exactly. The recent literature, however, stresses the importance of presenting confidence intervals for cost-effectiveness ratios in the analysis of health care programmes. This paper compares the use of several methods to obtain confidence intervals for the cost-effectiveness of a randomized intervention to increase the use of Medicaid's Early and Periodic Screening, Diagnosis and Treatment (EPSDT) programme. Comparisons of the intervals show that methods that account for skewness in the distribution of the ratio estimator may be substantially preferable in practice to methods that assume the cost-effectiveness ratio estimator is normally distributed. We show that non-parametric bootstrap methods that are mathematically less complex but computationally more rigorous result in confidence intervals that are similar to the intervals from a parametric method that adjusts for skewness in the distribution of the ratio. The analyses also show that the modest sample sizes needed to detect statistically significant effects in a randomized trial may result in confidence intervals for estimates of cost-effectiveness that are much wider than the boundaries obtained from deterministic sensitivity analyses.

Mesh:

Year:  1996        PMID: 8841654     DOI: 10.1002/(SICI)1097-0258(19960715)15:13<1447::AID-SIM267>3.0.CO;2-V

Source DB:  PubMed          Journal:  Stat Med        ISSN: 0277-6715            Impact factor:   2.373


  67 in total

1.  Handling uncertainty in economic evaluations of healthcare interventions.

Authors:  A H Briggs; A M Gray
Journal:  BMJ       Date:  1999-09-04

Review 2.  The use of the bootstrap statistical method for the pharmacoeconomic cost analysis of skewed data.

Authors:  A Desgagné; A M Castilloux; J F Angers; J LeLorier
Journal:  Pharmacoeconomics       Date:  1998-05       Impact factor: 4.981

Review 3.  Sample size determination for cost-effectiveness trials.

Authors:  Andrew R Willan
Journal:  Pharmacoeconomics       Date:  2011-11       Impact factor: 4.981

4.  Cost-effectiveness of the strong African American families-teen program: 1-year follow-up.

Authors:  Justin B Ingels; Phaedra S Corso; Steve M Kogan; Gene H Brody
Journal:  Drug Alcohol Depend       Date:  2013-08-15       Impact factor: 4.492

5.  Simulating the real world of antihyperglycaemic therapies in type 2 diabetes.

Authors:  Amanda I Adler
Journal:  Pharmacoeconomics       Date:  2006       Impact factor: 4.981

6.  How Chiropractors began working in a Community Health Centre in Ottawa.

Authors:  Neil B Baskerville; Dirk Keenan
Journal:  J Can Chiropr Assoc       Date:  2005-03

7.  Lessons from trial-based cost-effectiveness analyses of mental health interventions: why uncertainty about the outcome, estimate and willingness to pay matters.

Authors:  Jeffrey S Hoch; Carolyn S Dewa
Journal:  Pharmacoeconomics       Date:  2007       Impact factor: 4.981

8.  A randomized trial comparing the cost-effectiveness of 2 approaches for treating unilateral nasolacrimal duct obstruction.

Authors: 
Journal:  Arch Ophthalmol       Date:  2012-12

9.  Cost-effectiveness of lung volume reduction surgery.

Authors:  Scott D Ramsey; Sean D Sullivan; Robert M Kaplan
Journal:  Proc Am Thorac Soc       Date:  2008-05-01

Review 10.  Primary HPV screening for cervical cancer prevention: results from European trials.

Authors:  Elsebeth Lynge; Matejka Rebolj
Journal:  Nat Rev Clin Oncol       Date:  2009-11-10       Impact factor: 66.675

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.